Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanoparticles | 49 | 2023 | 1959 | 7.340 |
Why?
|
RNA, Small Interfering | 19 | 2023 | 3430 | 2.650 |
Why?
|
Nanomedicine | 11 | 2022 | 290 | 1.990 |
Why?
|
Drug Delivery Systems | 18 | 2023 | 2226 | 1.940 |
Why?
|
Nanotechnology | 12 | 2023 | 714 | 1.780 |
Why?
|
Polymers | 15 | 2023 | 1617 | 1.580 |
Why?
|
Drug Carriers | 7 | 2021 | 706 | 1.200 |
Why?
|
Melanins | 2 | 2021 | 290 | 1.130 |
Why?
|
RNA, Messenger | 8 | 2023 | 12794 | 1.110 |
Why?
|
Gene Transfer Techniques | 6 | 2017 | 1206 | 1.040 |
Why?
|
Lipids | 5 | 2021 | 3341 | 0.990 |
Why?
|
RNA | 4 | 2023 | 2726 | 0.940 |
Why?
|
Cancer Vaccines | 3 | 2020 | 1051 | 0.920 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1115 | 0.910 |
Why?
|
Polyethylene Glycols | 10 | 2021 | 1189 | 0.900 |
Why?
|
Antioxidants | 3 | 2021 | 1668 | 0.850 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2917 | 0.810 |
Why?
|
Neoplasms | 18 | 2021 | 22173 | 0.770 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3877 | 0.750 |
Why?
|
Nucleic Acids | 1 | 2023 | 188 | 0.730 |
Why?
|
Dendrimers | 1 | 2020 | 72 | 0.670 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 181 | 0.660 |
Why?
|
Mice, Nude | 9 | 2019 | 3614 | 0.620 |
Why?
|
Plaque, Atherosclerotic | 6 | 2024 | 1533 | 0.610 |
Why?
|
Cell Line, Tumor | 19 | 2023 | 16986 | 0.600 |
Why?
|
Hydrogels | 1 | 2023 | 720 | 0.570 |
Why?
|
HeLa Cells | 9 | 2017 | 3094 | 0.550 |
Why?
|
Photochemotherapy | 1 | 2023 | 823 | 0.540 |
Why?
|
RNA Interference | 5 | 2021 | 2832 | 0.530 |
Why?
|
Phospholipids | 3 | 2008 | 786 | 0.500 |
Why?
|
Nanostructures | 5 | 2020 | 553 | 0.490 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 399 | 0.440 |
Why?
|
Atherosclerosis | 9 | 2024 | 3408 | 0.440 |
Why?
|
Robotics | 1 | 2020 | 819 | 0.430 |
Why?
|
Lipid Bilayers | 3 | 2008 | 383 | 0.380 |
Why?
|
Reactive Oxygen Species | 5 | 2023 | 2141 | 0.380 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 733 | 0.380 |
Why?
|
Repressor Proteins | 3 | 2020 | 2986 | 0.370 |
Why?
|
Hydrogen-Ion Concentration | 5 | 2019 | 2496 | 0.360 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2057 | 0.360 |
Why?
|
Serum Albumin, Bovine | 2 | 2008 | 321 | 0.360 |
Why?
|
G(M1) Ganglioside | 2 | 2008 | 87 | 0.360 |
Why?
|
Animals | 41 | 2024 | 168467 | 0.340 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2021 | 695 | 0.340 |
Why?
|
Blood Platelets | 1 | 2020 | 2479 | 0.330 |
Why?
|
Macrophages | 8 | 2024 | 5769 | 0.330 |
Why?
|
Biocompatible Materials | 3 | 2019 | 1685 | 0.320 |
Why?
|
Mice | 26 | 2024 | 81533 | 0.320 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 11122 | 0.320 |
Why?
|
Pharmaceutical Preparations | 4 | 2023 | 1089 | 0.320 |
Why?
|
Phagocytosis | 3 | 2024 | 1528 | 0.310 |
Why?
|
Molecular Imprinting | 1 | 2008 | 12 | 0.310 |
Why?
|
Apoptosis | 8 | 2024 | 9489 | 0.310 |
Why?
|
Cholera Toxin | 2 | 2008 | 559 | 0.300 |
Why?
|
Immunotherapy | 3 | 2022 | 4652 | 0.300 |
Why?
|
Biological Products | 1 | 2017 | 914 | 0.300 |
Why?
|
Particle Size | 4 | 2017 | 1648 | 0.290 |
Why?
|
Tissue Distribution | 4 | 2021 | 2264 | 0.280 |
Why?
|
Prodrugs | 2 | 2019 | 261 | 0.270 |
Why?
|
Hydrogen Peroxide | 2 | 2021 | 730 | 0.260 |
Why?
|
Gene Silencing | 4 | 2017 | 1509 | 0.260 |
Why?
|
Membrane Lipids | 1 | 2007 | 252 | 0.260 |
Why?
|
Surface Properties | 5 | 2021 | 1161 | 0.260 |
Why?
|
Tissue Engineering | 2 | 2019 | 1868 | 0.260 |
Why?
|
Genetic Vectors | 1 | 2015 | 3396 | 0.260 |
Why?
|
Nanocapsules | 2 | 2020 | 94 | 0.250 |
Why?
|
Mice, Inbred C57BL | 10 | 2022 | 22172 | 0.250 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13382 | 0.240 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1229 | 0.240 |
Why?
|
Protein Interaction Mapping | 1 | 2008 | 616 | 0.240 |
Why?
|
Collagen Type IV | 2 | 2021 | 126 | 0.220 |
Why?
|
Levodopa | 2 | 2021 | 221 | 0.220 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 117 | 0.220 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6214 | 0.220 |
Why?
|
Brain Ischemia | 1 | 2017 | 3049 | 0.210 |
Why?
|
Anti-Inflammatory Agents | 3 | 2021 | 1809 | 0.210 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13642 | 0.210 |
Why?
|
Proteins | 4 | 2023 | 6032 | 0.210 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2332 | 0.210 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.210 |
Why?
|
Tryptophan | 1 | 2024 | 482 | 0.200 |
Why?
|
Humans | 52 | 2024 | 761572 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 220 | 0.200 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2008 | 803 | 0.190 |
Why?
|
Delayed-Action Preparations | 2 | 2016 | 962 | 0.190 |
Why?
|
Indocyanine Green | 1 | 2023 | 233 | 0.190 |
Why?
|
Putrescine | 1 | 2021 | 42 | 0.190 |
Why?
|
Ornithine Decarboxylase | 1 | 2021 | 63 | 0.180 |
Why?
|
Urease | 1 | 2020 | 39 | 0.180 |
Why?
|
Genes, abl | 1 | 2020 | 69 | 0.180 |
Why?
|
Enzymes, Immobilized | 1 | 2020 | 52 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2022 | 4580 | 0.180 |
Why?
|
Oxidative Stress | 3 | 2021 | 3113 | 0.180 |
Why?
|
Dendritic Cells | 3 | 2020 | 2747 | 0.170 |
Why?
|
Endothelial Cells | 2 | 2024 | 3548 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3603 | 0.170 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2020 | 174 | 0.170 |
Why?
|
Hydrodynamics | 1 | 2020 | 168 | 0.160 |
Why?
|
Transfection | 2 | 2018 | 5774 | 0.160 |
Why?
|
Benzylamines | 2 | 2017 | 247 | 0.160 |
Why?
|
Phosphorus | 2 | 2017 | 336 | 0.160 |
Why?
|
Ovalbumin | 1 | 2020 | 677 | 0.160 |
Why?
|
Photosensitizing Agents | 1 | 2023 | 623 | 0.160 |
Why?
|
Silicon Dioxide | 1 | 2019 | 216 | 0.160 |
Why?
|
Benzoates | 2 | 2017 | 212 | 0.150 |
Why?
|
Autophagy | 2 | 2024 | 1326 | 0.150 |
Why?
|
Infrared Rays | 2 | 2017 | 247 | 0.150 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18253 | 0.150 |
Why?
|
Membrane Potentials | 1 | 2021 | 1090 | 0.150 |
Why?
|
Hydroxyl Radical | 1 | 2018 | 82 | 0.150 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2018 | 80 | 0.150 |
Why?
|
Phototherapy | 2 | 2019 | 368 | 0.150 |
Why?
|
Cisplatin | 3 | 2019 | 1652 | 0.150 |
Why?
|
Osmotic Pressure | 1 | 2018 | 138 | 0.140 |
Why?
|
Methacrylates | 1 | 2017 | 109 | 0.140 |
Why?
|
Receptors, CXCR4 | 1 | 2022 | 727 | 0.140 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 578 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 1 | 2021 | 1062 | 0.140 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2017 | 82 | 0.140 |
Why?
|
Molecular Structure | 2 | 2020 | 1880 | 0.140 |
Why?
|
Bone Regeneration | 1 | 2019 | 432 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5315 | 0.140 |
Why?
|
Motion | 1 | 2020 | 779 | 0.130 |
Why?
|
Antibodies | 2 | 2019 | 2418 | 0.130 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 61 | 0.130 |
Why?
|
Peptides | 2 | 2019 | 4358 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2019 | 934 | 0.130 |
Why?
|
Ferric Compounds | 1 | 2018 | 378 | 0.130 |
Why?
|
Quantum Dots | 1 | 2017 | 167 | 0.130 |
Why?
|
Ligands | 2 | 2017 | 3272 | 0.130 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 686 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2468 | 0.120 |
Why?
|
Protein Engineering | 1 | 2019 | 549 | 0.120 |
Why?
|
Glutarates | 1 | 2017 | 243 | 0.120 |
Why?
|
Azepines | 1 | 2017 | 329 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 678 | 0.120 |
Why?
|
Endosomes | 1 | 2018 | 522 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1962 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5305 | 0.120 |
Why?
|
Boronic Acids | 2 | 2021 | 915 | 0.120 |
Why?
|
Fibronectins | 1 | 2018 | 723 | 0.120 |
Why?
|
Endocytosis | 1 | 2019 | 957 | 0.120 |
Why?
|
Receptors, LDL | 1 | 2017 | 488 | 0.120 |
Why?
|
Pharmacokinetics | 1 | 2014 | 86 | 0.120 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2811 | 0.110 |
Why?
|
Interleukin-10 | 2 | 2021 | 1175 | 0.110 |
Why?
|
Chlamydia trachomatis | 1 | 2015 | 239 | 0.110 |
Why?
|
Protein Binding | 5 | 2021 | 9353 | 0.110 |
Why?
|
Reference Standards | 1 | 2017 | 1003 | 0.110 |
Why?
|
Gold | 2 | 2017 | 482 | 0.110 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2021 | 398 | 0.110 |
Why?
|
Cells | 1 | 2014 | 165 | 0.110 |
Why?
|
Bacterial Vaccines | 1 | 2015 | 401 | 0.110 |
Why?
|
Polyglycolic Acid | 1 | 2014 | 406 | 0.100 |
Why?
|
Oxygen | 2 | 2021 | 4227 | 0.100 |
Why?
|
Antigens, Surface | 1 | 2017 | 1606 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3810 | 0.100 |
Why?
|
Inflammation | 4 | 2024 | 10773 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2018 | 1154 | 0.100 |
Why?
|
Doxorubicin | 1 | 2019 | 2224 | 0.100 |
Why?
|
Equipment Design | 1 | 2020 | 3511 | 0.100 |
Why?
|
Adjuvants, Immunologic | 2 | 2015 | 1036 | 0.100 |
Why?
|
Male | 13 | 2022 | 360842 | 0.100 |
Why?
|
Chlamydia Infections | 1 | 2015 | 365 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2018 | 815 | 0.100 |
Why?
|
Uterus | 1 | 2015 | 649 | 0.090 |
Why?
|
Vaccines, Synthetic | 1 | 2014 | 616 | 0.090 |
Why?
|
Collagen | 1 | 2019 | 2638 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3769 | 0.090 |
Why?
|
Mice, SCID | 1 | 2016 | 2626 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3713 | 0.090 |
Why?
|
Biological Transport | 1 | 2015 | 2091 | 0.090 |
Why?
|
Disulfides | 3 | 2018 | 465 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2012 | 165 | 0.090 |
Why?
|
Cysteine | 1 | 2015 | 891 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2021 | 14416 | 0.090 |
Why?
|
Th1 Cells | 1 | 2015 | 1036 | 0.090 |
Why?
|
Vaccination | 2 | 2020 | 3384 | 0.090 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2012 | 290 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2456 | 0.080 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2385 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2297 | 0.080 |
Why?
|
Iron | 1 | 2018 | 1793 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6132 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2865 | 0.080 |
Why?
|
Lactic Acid | 1 | 2014 | 1139 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 2012 | 417 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1902 | 0.080 |
Why?
|
Borates | 1 | 2008 | 19 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1359 | 0.080 |
Why?
|
Pyrazines | 1 | 2014 | 1201 | 0.080 |
Why?
|
Signal Transduction | 2 | 2024 | 23447 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2021 | 10448 | 0.080 |
Why?
|
Silicates | 1 | 2008 | 47 | 0.080 |
Why?
|
Liver | 2 | 2021 | 7529 | 0.070 |
Why?
|
Haptens | 1 | 2008 | 163 | 0.070 |
Why?
|
Oxidation-Reduction | 3 | 2020 | 2231 | 0.070 |
Why?
|
Contrast Media | 1 | 2021 | 5311 | 0.070 |
Why?
|
Antigen-Antibody Reactions | 1 | 2008 | 340 | 0.070 |
Why?
|
Glass | 1 | 2008 | 115 | 0.070 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 253 | 0.070 |
Why?
|
Cells, Cultured | 5 | 2021 | 18965 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2057 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4319 | 0.070 |
Why?
|
Glutathione | 2 | 2018 | 583 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3449 | 0.060 |
Why?
|
Models, Chemical | 1 | 2008 | 611 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3677 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5672 | 0.060 |
Why?
|
DNA | 2 | 2020 | 7213 | 0.060 |
Why?
|
Kynurenine | 1 | 2024 | 141 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2021 | 64684 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6312 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 75 | 0.050 |
Why?
|
Rabbits | 2 | 2019 | 4772 | 0.050 |
Why?
|
Cattle | 1 | 2008 | 3849 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5799 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1251 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 191 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2529 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3085 | 0.050 |
Why?
|
Microfluidics | 1 | 2007 | 653 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 366 | 0.050 |
Why?
|
Cholesterol | 2 | 2022 | 2904 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2010 | 2199 | 0.050 |
Why?
|
Basement Membrane | 1 | 2021 | 349 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2645 | 0.040 |
Why?
|
Drug Compounding | 1 | 2021 | 246 | 0.040 |
Why?
|
Rats | 1 | 2017 | 23741 | 0.040 |
Why?
|
Female | 8 | 2022 | 392686 | 0.040 |
Why?
|
Cytoplasm | 2 | 2018 | 1510 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 1784 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6597 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6346 | 0.040 |
Why?
|
Aptamers, Peptide | 1 | 2018 | 28 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 738 | 0.040 |
Why?
|
Porosity | 1 | 2019 | 349 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2002 | 852 | 0.040 |
Why?
|
Biomimetics | 1 | 2019 | 171 | 0.040 |
Why?
|
Biomimetic Materials | 1 | 2019 | 172 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2019 | 255 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 802 | 0.040 |
Why?
|
Molybdenum | 1 | 2017 | 46 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12129 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 311 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 211 | 0.040 |
Why?
|
Joints | 1 | 2019 | 322 | 0.040 |
Why?
|
Cell Survival | 2 | 2019 | 5791 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1444 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 867 | 0.030 |
Why?
|
Graphite | 1 | 2017 | 78 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2019 | 438 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 718 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5146 | 0.030 |
Why?
|
Th17 Cells | 1 | 2022 | 794 | 0.030 |
Why?
|
Amides | 1 | 2018 | 449 | 0.030 |
Why?
|
Anisotropy | 1 | 2019 | 1283 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 198 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2017 | 453 | 0.030 |
Why?
|
Cartilage | 1 | 2019 | 806 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 364 | 0.030 |
Why?
|
Skull | 1 | 2019 | 818 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2015 | 95 | 0.030 |
Why?
|
Vaccines, Inactivated | 1 | 2015 | 179 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2002 | 2192 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2002 | 953 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7396 | 0.030 |
Why?
|
Orphan Nuclear Receptors | 1 | 2014 | 63 | 0.030 |
Why?
|
Chondrocytes | 1 | 2019 | 795 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1486 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36429 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2022 | 11530 | 0.030 |
Why?
|
Toll-Like Receptor 8 | 1 | 2014 | 99 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 197 | 0.030 |
Why?
|
KB Cells | 1 | 2012 | 13 | 0.030 |
Why?
|
Alendronate | 1 | 2014 | 175 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2015 | 421 | 0.030 |
Why?
|
Toll-Like Receptor 7 | 1 | 2014 | 177 | 0.030 |
Why?
|
Osteogenesis | 1 | 2019 | 1273 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2014 | 233 | 0.030 |
Why?
|
Platinum | 1 | 2013 | 220 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 779 | 0.020 |
Why?
|
Luciferases | 1 | 2013 | 714 | 0.020 |
Why?
|
Taxoids | 1 | 2015 | 668 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2015 | 659 | 0.020 |
Why?
|
Peritonitis | 1 | 2014 | 368 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21017 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 7858 | 0.020 |
Why?
|
Oligopeptides | 1 | 2016 | 1187 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2016 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2580 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1080 | 0.020 |
Why?
|
Regeneration | 1 | 2019 | 1512 | 0.020 |
Why?
|
Triglycerides | 1 | 2017 | 2461 | 0.020 |
Why?
|
Antibody Formation | 1 | 2014 | 1395 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3080 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1642 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3466 | 0.020 |
Why?
|
Antigens | 1 | 2014 | 1443 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1560 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1180 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2226 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2295 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4369 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1802 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4280 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16592 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4001 | 0.010 |
Why?
|
Models, Biological | 1 | 2021 | 9469 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3429 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17352 | 0.010 |
Why?
|
Communicable Disease Control | 1 | 2010 | 846 | 0.010 |
Why?
|
Gold Colloid | 1 | 2002 | 12 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.010 |
Why?
|
Carcinoma | 1 | 2012 | 2330 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11904 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15601 | 0.010 |
Why?
|
Binding Sites | 1 | 2008 | 6056 | 0.010 |
Why?
|
Immunoassay | 1 | 2002 | 745 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6241 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58986 | 0.010 |
Why?
|
Aged | 1 | 2018 | 169310 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 220920 | 0.000 |
Why?
|
Adult | 1 | 2018 | 221203 | 0.000 |
Why?
|